Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Massive obstetric hemorrhage.

Zoltán Papp1

  • 1I. Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.

Journal of Perinatal Medicine
|November 7, 2003
PubMed
Summary
This summary is machine-generated.

Massive obstetric hemorrhage, a leading cause of maternal death, requires prompt management of hypovolemia and coagulation defects. Effective treatment involves rapid fluid replacement, blood products, and timely surgical intervention to control bleeding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The application of artificial intelligence in healthcare: benefits, challenges, and issues of responsibility].

Orvosi hetilap·2026
Same author

Myofilament-level effects of aficamten increase diastolic chamber volumes and maintain cardiac output through preserved length-dependent force generation in healthy rat and canine myocardium.

Basic research in cardiology·2026
Same author

Tissue-specific autoantibody signatures reveal immune alterations undetected by routine serology in long COVID.

GeroScience·2026
Same author

[Professor János Hankiss is 100 years old].

Orvosi hetilap·2026
Same author

[Dr. Albert Béla Jankó (1934-2024)].

Orvosi hetilap·2026
Same author

Orvosi hetilap·2026

Area of Science:

  • Obstetrics and Gynecology
  • Maternal Health
  • Hemorrhage Management

Background:

  • Massive obstetric hemorrhage is a significant contributor to maternal mortality and morbidity.
  • Key causes include placental abruption, placenta previa, and postpartum hemorrhage.
  • Avoidable factors in maternal deaths from hemorrhage involve delays in correcting hypovolemia, coagulation issues, and surgical bleeding control.

Purpose of the Study:

  • To outline the critical management strategies for massive obstetric hemorrhage.
  • To emphasize the importance of prompt and adequate volume replacement and coagulation correction.
  • To highlight necessary surgical interventions for controlling severe bleeding.

Main Methods:

  • Maintaining effective circulating intravascular volume through prompt and adequate replacement of blood, crystalloids, or fresh-frozen plasma.

Related Experiment Videos

  • Utilizing multiple intravenous lines and potentially pressure-assisted infusion with continuous hemodynamic monitoring.
  • Prioritizing rapid correction of hypovolemia with crystalloids and red blood cells, followed by blood component therapy.

    • Main Results:

    • Uterine atony can be managed with oxytocin and prostaglandins.
    • Traumatic bleeding necessitates appropriate surgical intervention.
    • Ligation of uterine, ovarian, and hypogastric arteries, or arterial embolization, effectively controls uterine bleeding in most cases.
    • Emergency hysterectomy is a consideration for severe, intractable hemorrhage.

    Conclusions:

    • Gynecologists must be proficient in immediate operative maneuvers, including hypogastric artery ligation and emergency hysterectomy, to control obstetric bleeding.
    • Recent recognition of the extent and importance of postnatal maternal morbidity is crucial.
    • Effective management hinges on timely interventions addressing hypovolemia, coagulation, and surgical control.